Corporate Overview

Scion NeuroStim, Inc. was founded by Les Rogers M.D. and Lanty Smith. Their vision was to develop a non-invasive device that patients could use at home to treat neurological conditions. From the outset, the company has been committed to rigorous clinical science to best define the role of neuromodulation in clinical practice.

Backed by Science

Scion’s primary focus is the development of a home use, non-invasive treatment for Parkinson’s disease. To this end, Scion is sponsoring a double-blind, randomized controlled clinical trial at more than twenty centers. This study includes people with Parkinson’s motor and non-motor symptoms that are not adequately treated by drug therapy. If successful, Parkinson’s disease will be the first commercial application of Scion’s platform technology.

Scion's Neuromodulation Device

Scion’s neuromodulation device looks like music headphones attached to a tabletop console. Patients wear the non-invasive device for twenty minutes at a time, twice a day, at home. No surgery or assistance from a medical professional will be required once a patient is trained. During each session, patients can choose to read, watch television or listen to music. Prior clinical studies have demonstrated high treatment adherence and excellent tolerability (Wilkinson, Ade et al 2017; Wilkinson 2019).

Caution: Investigational Device: Limited by United States law to investigational use. For clinical research only.


Lanty Smith

Chief Executive Officer

View Bio

Robert Black, PhD

Chief Operating Officer &
Chief Technology Officer

View Bio

Lesco Rogers, M.D.

Senior Vice President &
Chief Medical Officer

View Bio

Kristen Ade, PhD

Vice President & Chief
Scientific Officer

View Bio

Nat Bowditch

Executive Vice President

View Bio

Kara Richardson

Vice President Clinical

View Bio

Jemica Warren

Director of Clinical Affairs

View Bio

Amanda Tucker

Director of Engineering

View Bio